# FDA EIR - Andre Kalil, M.D. - January 14, 2022

Source: https://www.globalkeysolutions.net/records/eir/andre-kalil-md/4601a00c-f951-4c1c-8b4e-f12c7ff5a30c

> FDA EIR for Andre Kalil, M.D. on January 14, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: Andre Kalil, M.D.
- Inspection Date: 2022-01-14
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2022-01-14](https://www.globalkeysolutions.net/records/483/andre-kalil-md/7bf08e2b-f585-4584-8ed6-665ac26e0c25)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/courtney-r-bratina/3ad4bfd5-d0da-4801-8e90-a5a3ba9291c3)
- [company_representative](https://www.globalkeysolutions.net/people/susan-m-leister/723b4123-b44b-4fac-af76-26db769e4ef2)
- [company_representative](https://www.globalkeysolutions.net/people/luann-r-larson/c7444182-624e-4e97-b0ba-b92e6eeb6e7e)
- [recipient](https://www.globalkeysolutions.net/people/andre-c-kalil/f586fb52-417c-4ad3-90e1-cafac3ca43c5)

Company: https://www.globalkeysolutions.net/companies/andre-kalil-md/102c177d-3d38-47df-8ec3-82cbb1fc3b51

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c